SCHEMBL7586193

SCHEMBL7586193

OC=CCC1CCNCC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.35
ALOX15 P16050 2/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35
GABRA5 P31644 3/20 0.34
GABRB2 P47870 3/20 0.34
SLC6A1 P30531 2/20 0.34
SLC6A12 P48065 2/20 0.34
SLC6A11 P48066 2/20 0.34
SLC6A13 Q9NSD5 2/20 0.34
GABRA1 P14867 2/20 0.34
GABRA4 P48169 2/20 0.34
GABRR1 P24046 1/20 0.34
GBA1 P04062 3/20 0.33
CPN1 P15169 1/20 0.33
CPB2 Q96IY4 1/20 0.33
GNAI3 P08754 1/20 0.32
GNAO1 P09471 1/20 0.32
GNAI1 P63096 1/20 0.32
GABRP O00591 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7698450 1.00 TSHR (0.35) TSHRALOX15CHRM1CHRM3GABRA5
SCHEMBL8764248 0.82
SCHEMBL4793565 0.77
SCHEMBL4019383 0.76 CHRM1 (0.35) TSHRALOX15CHRM1CHRM3GABRA5
SCHEMBL10154182 0.76 NOS2 (0.35) TSHRALOX15CHRM1CHRM3GABRA5
SCHEMBL728990 0.76 TSHR (0.35) TSHRALOX15CHRM1CHRM3GABRA5
SCHEMBL25610380 0.76 NOS2 (0.35) TSHRALOX15CHRM1CHRM3GABRA5
SCHEMBL4793553 0.75 ADH1B (0.34) CHRM1
SCHEMBL7138787 0.74 GBA1 (0.38) TSHRALOX15CHRM1CHRM3GABRA5
SCHEMBL18585917 0.73 TSHR (0.38) TSHRALOX15CHRM1CHRM3GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002079190-A1 3-SUBSTITUTED INDOLES AS CHEMOKINE ANTAGONISTS SMITHKLINE BEECHAM P.L.C. (GB) 2002-10-10 WO disclosed
EP-1215215-A1 Platelet aggregation inhibitors containing c-terminal aminergic side chain amino acid residues G.D. SEARLE & CO. (US) 2002-06-19 EP disclosed
US-5811398-A Platelet aggregation inhibitors containing C-terminal aminergic side chain amino acid residues G. D. SEARLE & CO. (US) 1998-09-22 US disclosed
EP-0835265-A1 PLATELET AGGREGATION INHIBITORS CONTAINING C-TERMINAL AMINERGIC SIDE CHAIN AMINO ACID RESIDUES G.D. SEARLE & CO. (US) 1998-04-15 EP disclosed
EP-0605031-B1 Phenoxy- and phenoxyalkyl-piperidines as antiviral agents SANOFI SA (FR) 1997-07-16 EP disclosed
WO-1996032415-A1 PLATELET AGGREGATION INHIBITORS CONTAINING C-TERMINAL AMINERGIC SIDE CHAIN AMINO ACID RESIDUES G.D. SEARLE & CO. (US) 1996-10-17 WO disclosed
US-5364865-A Phenoxy- and phenoxyalkyl-piperidines as antiviral agents STERLING WINTHROP INC. (US) 1994-11-15 US disclosed
EP-0605031-A1 Phenoxy- and phenoxyalkyl-piperidines as antiviral agents STERLING WINTHROP INC. (US) 1994-07-06 EP disclosed
EP-0577217-A1 Tetrazolyl-(phenoxy and phenoxyalkyl) piperidininylpyridazines as antiviral agents STERLING WINTHROP INC. (US) 1994-01-05 EP disclosed
US-5268351-A Containing a perhydro(iso)quinoline ring structure BASF AKTIENGESELLSCHAFT (DE) 1993-12-07 US disclosed
US-5242924-A Tetrazolyl-(phenoxy and phenoxyalkyl)-piperidinylpyridazines as antiviral agents STERLING WINTHROP INC. (US) 1993-09-07 US disclosed
US-5175295-A Mildewicides BASF AKTIENGESELLSCHAFT (DE) 1992-12-29 US disclosed